These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26647895)

  • 21. The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.
    Curtis NJ; Primrose JN; Thomas GJ; Mirnezami AH; Ottensmeier CH
    Eur J Surg Oncol; 2012 Oct; 38(10):889-96. PubMed ID: 22721580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
    Zlobec I; Baker K; Minoo P; Hayashi S; Terracciano L; Lugli A
    Cancer; 2009 Sep; 115(17):4021-9. PubMed ID: 19517467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
    Bruni D; Angell HK; Galon J
    Nat Rev Cancer; 2020 Nov; 20(11):662-680. PubMed ID: 32753728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corelation of lymphocytic infiltrates with the prognosis of recurrent colo-rectal cancer.
    Makkai-Popa ST; Luncă S; Dimofte G; Vrânceanu A; Franciug D; Ivanov I; Zugun F; Târcoveanu E; Carasevici E
    Chirurgia (Bucur); 2013; 108(6):859-65. PubMed ID: 24331327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Efficient Prognostic Immune Scoring System For Colorectal Cancer Patients With Peritoneal Metastasis.
    Zhao Y; Chen C; Xu X; Ge X; Ding K; Zheng S; Wang J; Sun L
    Oncoimmunology; 2021 Mar; 10(1):1901464. PubMed ID: 33796414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.
    Mlecnik B; Tosolini M; Kirilovsky A; Berger A; Bindea G; Meatchi T; Bruneval P; Trajanoski Z; Fridman WH; Pagès F; Galon J
    J Clin Oncol; 2011 Feb; 29(6):610-8. PubMed ID: 21245428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients.
    Baldin P; Van den Eynde M; Mlecnik B; Galon J
    Oncoimmunology; 2020 Oct; 9(1):1826133. PubMed ID: 33110705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.
    Mlecnik B; Lugli A; Bindea G; Marliot F; Bifulco C; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert CI; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang J; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Lafontaine L; Maby P; Majdi A; Hijazi A; El Sissy C; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; van de Water C; Vliet SVL; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Patel P; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Fox BA; Pagès F; Galon J
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of FOXP3+ T regulatory cells in colorectal cancer.
    Vlad C; Kubelac P; Fetica B; Vlad D; Irimie A; Achimas-Cadariu P
    J BUON; 2015; 20(1):114-9. PubMed ID: 25778305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.
    Mlecnik B; Torigoe T; Bindea G; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Hirohashi Y; Furuhata T; Takemasa I; Patel P; Vora H; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Yoshino T; Taniguchi H; Bifulco C; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert CI; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang J; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson E; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Marliot F; Fredriksen T; Buttard B; Lafontaine L; Maby P; Majdi A; Hijazi A; El Sissy C; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; Van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Marincola FM; Ascierto PA; Fox BA; Pagès F; Kawakami Y; Galon J
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study.
    Reichling C; Taieb J; Derangere V; Klopfenstein Q; Le Malicot K; Gornet JM; Becheur H; Fein F; Cojocarasu O; Kaminsky MC; Lagasse JP; Luet D; Nguyen S; Etienne PL; Gasmi M; Vanoli A; Perrier H; Puig PL; Emile JF; Lepage C; Ghiringhelli F
    Gut; 2020 Apr; 69(4):681-690. PubMed ID: 31780575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin.
    Remark R; Alifano M; Cremer I; Lupo A; Dieu-Nosjean MC; Riquet M; Crozet L; Ouakrim H; Goc J; Cazes A; Fléjou JF; Gibault L; Verkarre V; Régnard JF; Pagès ON; Oudard S; Mlecnik B; Sautès-Fridman C; Fridman WH; Damotte D
    Clin Cancer Res; 2013 Aug; 19(15):4079-91. PubMed ID: 23785047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer Survival.
    Satoyoshi T; Hirohashi Y; Okuya K; Miyo M; Akizuki E; Ishii M; Miura R; Kubo T; Murata K; Kanaseki T; Tsukahara T; Takemasa I; Torigoe T
    Anticancer Res; 2024 Apr; 44(4):1603-1610. PubMed ID: 38537969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy.
    Halama N; Michel S; Kloor M; Zoernig I; Benner A; Spille A; Pommerencke T; von Knebel DM; Folprecht G; Luber B; Feyen N; Martens UM; Beckhove P; Gnjatic S; Schirmacher P; Herpel E; Weitz J; Grabe N; Jaeger D
    Cancer Res; 2011 Sep; 71(17):5670-7. PubMed ID: 21846824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016.
    Galon J; Lugli A; Bifulco C; Pages F; Masucci G; Marincola FM; Ascierto PA
    J Transl Med; 2017 Oct; 15(1):212. PubMed ID: 29058595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoscore: a novel prognostic tool. Association with clinical outcome, response to treatment and survival in several malignancies.
    Ros-Martínez S; Navas-Carrillo D; Alonso-Romero JL; Orenes-Piñero E
    Crit Rev Clin Lab Sci; 2020 Nov; 57(7):432-443. PubMed ID: 32175789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
    Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
    Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoscore
    Blair HA
    Mol Diagn Ther; 2020 Jun; 24(3):365-370. PubMed ID: 32232741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.
    Donnem T; Kilvaer TK; Andersen S; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Brustugun OT; Helland A; Lund-Iversen M; Solberg S; Gronberg BH; Wahl SG; Helgeland L; Fløtten O; Pohl M; Al-Shibli K; Sandanger TM; Pezzella F; Busund LT; Bremnes RM
    Ann Oncol; 2016 Feb; 27(2):225-32. PubMed ID: 26578726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.